Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 24 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

The mission of ETHA is to give the thrombosis and hemostasis community a voice and drive prioritisation of thrombosis and hemostasis in the EU patient safety and research programs. With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.

To learn more about ETHA’s initial area of priority, read the consensus statement, here.

News

Proud to Partner: World Thrombosis Day on 13 October

ETHA is proud to partner with World Thrombosis Day and more than 2,000 organizations across 100 countries in a united effort to reduce death and disability from thrombosis – the underlying cause of the world’s top three cardiova...

Continue reading

Invitation: Cancer-Associated Thrombosis Roundtable Discussi...

You Are Invited to Attend a Roundtable Discussion on Cancer-Associated Thrombosis and the EU Cancer Agenda Event in Recognition of World Thrombosis Day MEP Juozas Olekas and the European Thrombosis and Haemostasis Alliance (ETHA) ar...

Continue reading